STA To Market Sarcoma Drug In Australia, New Zealand And SE Asia Following License Deal

Corporate Breaking News

Home : STA To Market Sarcoma Drug In Australia, New Zealand And SE Asia Following License Deal

Oct 14 2019	STA To Market Sarcoma Drug In Australia, New Zealand And SE Asia Following License Deal
SINGAPORE and MELBOURNE, Australia, Oct. 14, 2019 /PRNewswire/ -- Independent pharmaceutical company Specialised Therapeutics Asia (STA) has signed a new license deal, enabling it to provide a global advanced sarcoma therapy to patients in Australia, New Zealand and throughout SE Asia....


Source:https://www.prnewswire.com:443/news-releases/sta-to-market-sarcoma-drug-in-australia-new-zealand-and-se-asia-following-license-deal-300937544.html

Related News
» Okayama University e-Bulletin: Promoting Sustainable Development Goals (SDGs) Across Generations by Launching SDGs Youth Project » Yourway Mitigates Uncertainty Of Brexit For Clinical Trials In Europe